newsfilter
← Latest News
Business Wire·

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

- Chief Medical Officer Amir Inamdar to participate in a panel on November 5, 2025 - Cybin Inc. (NYSE:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company